Jürgen Geisler

15PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsHaematological tumoursOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 29, 2026
Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus help to interpret the current evidence?

|Nov 06, 2025
Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges.

Mark Verrill, Michael Patrick Lux, Joseph Gligorov

|Aug 30, 2025
Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.

Torbjørn Omland, Siri Lagethon Heck, Espen Holte

|Mar 12, 2025
Germline variants in CDKN2A wild-type melanoma prone families.

Gjertrud T Iversen, Marie Loeng, Amalie Lund Holth

|Jul 29, 2024
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer.

Kamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler

|Jun 26, 2024
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition.

Leonard Schmiester, Fara Brasó-Maristany, Blanca González-Farré

Pageof 3

Frequent Collaborators

3 joint publications

Katja Vetvik

3 joint publications

Torill Sauer

2 joint publications

Mattia Russel Pantalone

1 joint publications

Afsar Rahbar